ProFound AI® Risk
Revolutionizing Personalized Screening
Now available for 2D and 3D mammography
Learn More
PowerLook® Density Assessment
The world’s first and only multi-vendor deep learning algorithm for standardizing breast density assessments using synthesized 2D images
Learn More
ProFound AI® Solutions - EU
The Complete Artificial Intelligence Solution for Breast Cancer Screening
Learn More
<
>
About iCAD
iCAD is a global leader in advanced breast cancer detection solutions built on artificial intelligence that empower radiologists to find cancers earlier while improving reading workflow. Our Breast Health Solutions suite delivers powerful detection and workflow solutions for 2D and 3D mammography.
Pandemic Recovery: How New Technology Can Support Clinicians and Patients in the Aftermath of COVID-19
As we shift from the peak of the pandemic to recovery mode, clinicians are in need of new solutions to navigate today’s challenges. During this virtual event, leading experts from the breast care community shared insights about new innovations in imaging and risk-assessment that may help the clinical community address emerging pandemic challenges, and best practices for how facilities can recuperate from the impact of COVID-19. Learn how the latest technology can help clinicians optimize workflow and patient care during the COVID-19 recovery period and beyond.
ProFound Recovery
Discover powerful AI solutions to overcome imaging challenges presented by the COVID-19 pandemic
LEARN MORE
From the Newsroom
October 7, 2021
iCAD Unveils Next Generation Technologies at Journées Francophones de Radiologie (October 8-11, Paris, France)September 29, 2021
iCAD Launches Revolutionary Short-term Personalized Risk Assessment Solution for 3D MammographySeptember 9, 2021
iCAD to Host Educational Roundtable to Help Clinicians and Facilities Recover from COVID-19 ImpactAugust 31, 2021
iCAD’s Xoft Brain IORT Demonstrates Significant Improvement in Overall Survival in Recurrent Glioblastoma According to Comparative StudyAugust 5, 2021
iCAD Reports Financial Results for the Quarter Ended June 30, 2021
» View all news »
Discover the Power of ProFound AI® for Digital Breast Tomosynthesis
Digital breast tomosynthesis (DBT) is rapidly replacing 2D mammography in breast cancer screening because of the clinical value it offers in cancer detection. However, it presents significant workload challenges for radiologists, which can affect patient care. ProFound AI® is clinically proven to assist radiologists by improving cancer detection, decreasing reading times and reducing false positives and costly patient recalls.
iNFORMED - BlogInform, connect and engage. We invite you to engage with us to participate on the topic of cancer detection solutions, patient stories, clinical expertise.View BlogMedia SpotlightThe New Normal - The Imaging Landscape in Late-Stage Pandemic DaysView ArticleClinical FeatureImproving reading time of digital breast tomosynthesis with concurrent computer aided detection.View White Paper
Supporting cancer detection for 3,500+ healthcare facilities worldwide
Speak to a specialist today at 1.866.280.2239
Engage Us
Products
ProFound AI Risk
ProFound AI for Digital Breast Tomosynthesis
ProFound AI Solutions - EU
SecondLook for 2D Mammography
Density Assessment
VeraLook Colon Polyp Detection
Resources
ProFound Institute
Educational Webinars
Clinical Resources
Customer Case Studies
Patient Resources
Compliance
Training & Support
EU Customer Portal
Precise and Powerful Healthcare Solutions
© iCAD Inc. All rights reserved. iCAD, the iCAD logo, PowerLook, ProFound AI, ProFound, Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are trademarks of iCAD, Inc. Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.